![Gérard Soula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gérard Soula
Gründer bei
ADOCIA
Vermögen: 6 Mio $ am 30.06.2026
Profil
Gérard Soula is the founder.
He founded Flamel Technologies SA in 1990, where he held the title of Chairman & Chief Executive Officer from 1990 to 2005.
He also founded Adocia SA in 2005 and currently serves as Chairman.
Dr. Soula's current job is as a Director at Glowbl SAS. His former positions include being a Director at Veloxis Pharmaceuticals A and Life Cycle Pharma A. Dr. Soula obtained a doctorate degree from Université d'Aix-Marseille.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADOCIA SA 5.96% | 13.03.2026 | 1’180’192 ( 5.96% ) | 6 Mio $ | 30.06.2026 |
Aktive Positionen von Gérard Soula
| Unternehmen | Position | Beginn |
|---|---|---|
| ADOCIA | Gründer | 16.12.2005 |
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gérard Soula
| Unternehmen | Position | Ende |
|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Gründer | 01.01.2005 |
Life Cycle Pharma A/S | Direktor/Vorstandsmitglied | - |
| VELOXIS PHARMACEUTICALS A/S | Direktor/Vorstandsmitglied | - |
Ausbildung von Gérard Soula
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Life Cycle Pharma A/S | |
Université d'Aix-Marseille
 Université d'Aix-Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing | Technology Services |
